Blog

Information Advocacy Research Experiences Reviews Media

Neurological Advisory Committee meeting presentation

September 20th 2023 That was the comment from Dr Brian Anderson, Chair of Pharmac’s Neurological Advisory Committee, when speaking about the collection of stories we gave to Pharmac and the Committee about people’s Read more

Highlights from International Headache Congress 2023

September 19th 2023 The International Headache Society (IHS) is the leading international headache charity, which exists to promote awareness and knowledge about headache worldwide, through science, education and Read more

WINZ contributes to Emgality costs

September 14th 2023 There aren’t many people in New Zealand who are on a benefit because of migraine, despite migraine being a common and disabling disease, that can seriously impair people’s ability to work. But if Read more

What the Women’s Health Strategy means for people with migraine in Aotearoa

August 29th 2023 In July 2023, the Ministry of Health launched six new health strategies, the Pae Ora | Healthy Futures Strategies, as mandated by new legislation (the Pae Ora Act) that underpinned the restructuring Read more

Lack of medicine access contributing to health workforce shortage

August 22nd 2023 Despite the hedging of various Ministers of Health, it’s hard to avoid the conclusion that our healthcare workforce is in crisis. People are waiting weeks to see a GP. Between 2019 and 2022, 28% Read more

What I learnt from a headache specialist

August 14th 2023 The New Zealand Pain Society is an organisation that promotes education and training in all areas of pain management and research. It regularly organises webinars for members, and on 10 August 2023 Read more

Twenty three survey key insight reports published

August 1st 2023 In August 2022, Migraine Foundation Aotearoa New Zealand undertook the first online survey of people with migraine in NZ (the Migraine in Aotearoa New Zealand survey). We did this because there was Read more

Medsafe recommends atogepant be added to medication schedule

July 13th 2023 Medsafe has recommended the gepant medication atogepant (Qulipta) be added to the New Zealand Medicines Schedule. Atogepant is used to prevent migraine and is taken daily as an oral tablet. Atogepan Read more

New migraine questions in the next New Zealand Health Survey

July 3rd 2023 A year ago in June 2022, Migraine Foundation Aotearoa New Zealand applied to the Ministry of Health to add questions about migraine to the New Zealand Health Survey, a national survey of over 13,000 Read more

Migraine Foundation Aotearoa New Zealand Incorporated is a registered charitable organisation under the Charities Act 2005. Our charity registration number is CC60312.

The information on this website is for informative purposes only. Migraine Foundation Aotearoa New Zealand is not a medical organisation. Please consult your healthcare professional for specific migraine treatment advice. All quotes featured on the website are real quotes from people in Aotearoa New Zealand living with migraine.

This website contains links to websites operated by third parties. Migraine Foundation Aotearoa New Zealand is not responsible for the content on these websites and provides links for reference only.

Latest news